期刊文献+

有机阴离子转运多肽活性及表达调控的影响因素 被引量:1

Regulation of organic anion transporting polypeptides expression and activity
原文传递
导出
摘要 有机阴离子转运多肽(organic anion transporting polypeptides,OATP)是一类重要的跨膜摄取转运体,属于溶质转运体(solute carrier,SLC)超家族,以Na+和ATP非依赖方式参与内源物(胆汁酸、胆红素、前列腺素、甲状腺激素和甾体激素结合物)、药物及毒物转运。多种因素(如激素、炎症因子和药物等)会影响OATP的分布、表达及活性,引起底物在组织器官内蓄积的改变,导致食物-药物及药物-药物相互作用。癌组织内OATP分布特性及表达变化可能参与肿瘤的病理过程。表观基因组学调节与OATP的特异性分布有关。本文就参与OATP表达及功能调控的因素进行综述,为药物研发及发病机制的阐明提供线索。 Organic anion transporting polypeptides(OATP), a member of solute carrier(SLC) superfamily, is considered as an important transmembrane uptake transporters. OATP is involved in the transport of a variety of endo- and xenobiotics(bile acids, bilirubin, prostaglandin, thyroid hormones, steroid hormone conjugates), drugs and toxins in a Na+ and ATP independent manner. Multiple factors(eg. hormones, proinflammatory cytokines, drugs) can affect the distribution, expression and activity of OATPs, leading to an altered accumulation of OATP substrates and related food-drug and drug-drug interactions. Changes in the distribution and expression of OATPs in malignant tissues may be related to the pathological process of cancer, while the modulation epigenetic mechanism also contributes to its distribution patterns. This review describes the factors that can affect the expression or function of OATPs, which may provide a valuable reference for drug development and the clarification of pathogenesis.
出处 《药学学报》 CAS CSCD 北大核心 2015年第4期400-405,共6页 Acta Pharmaceutica Sinica
基金 十二五新药创制重大专项资助项目(2012ZX09301002-001-007,2012ZX09301002-006,2012ZX09103-101-001)
关键词 有机阴离子转运多肽 表达 活性 调控 organic anion transporting polypeptide expression activity regulation
  • 相关文献

参考文献1

二级参考文献20

  • 1金汉珍,黄德珉,官希吉.实用新生儿学.3版.北京:人民卫生出版社.2004:516.
  • 2Cui Y,Konig J,Leier I,et al.Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6.J Biol Chem,2001,276:9626-9630.
  • 3Konig J,Cui Y,Nies AT,et al.A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane.Am J Physiol Gastrointest Liver Physical,2000,278:G156-164.
  • 4Choi JH,Lee MG,Cho JY,et al.Influence of OATP 1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans,ClinPharmacol Ther,2008,83:251-257.
  • 5Kullak-Ublick GA,Ismair MG,Stieger B,et al.Organic aniontransporting polypeptide B(OATP-B)and its functional comparison with three other OATPs of human liver.Gastroenterology,2001,120:525-533.
  • 6Tirona RG,Leake BF,Merino G,et al.Polymorphisms in OATPC:identification of multiple allelic variants associated with altered transport activity among European-and African-Americans.J Biol Chem,2001,276:35669-35675.
  • 7Ho RH,Choi L,Lee W,et al.Effect of drug transporter genntypes on pravastatin disposition in European-and AfricanAmerican participants.Pharmacogenet Genomics,2007,17:647-656.
  • 8KivistoKT,Niemi M.Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans.Pharm Res,2007,24:239-247.
  • 9Huang CS,Huang MJ,Lin MS,et al.Genetic factors related to unconjugated hyperbilirubinemia amongst adults.Pharmacogenet Genomics,2005,15:43-50.
  • 10Ieiri I,Suzuki H,Kimura M,et al.Influence of common variants in the pharmacokinetic genes(OATB-C,UGT1 Al,and MRP2)on serum bilirubin levels in healthy subjects.Hepatol Res,2004,30:91-95.

共引文献13

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部